Abingworth LLP Vera Therapeutics, Inc. Transaction History
Abingworth LLP
- $301 Million
- Q4 2022
A detailed history of Abingworth LLP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Abingworth LLP holds 2,960,231 shares of VERA stock, worth $112 Million. This represents 19.0% of its overall portfolio holdings.
Number of Shares
2,960,231
Previous 2,960,231
-0.0%
Holding current value
$112 Million
Previous $63.1 Million
9.2%
% of portfolio
19.0%
Previous 21.57%
Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
173Shares Held
52.7MCall Options Held
117KPut Options Held
290K-
Avoro Capital Advisors LLC New York, NY5.27MShares$200 Million2.74% of portfolio
-
Black Rock Inc. New York, NY3.32MShares$126 Million0.0% of portfolio
-
Commodore Capital LP New York, NY3.17MShares$120 Million11.79% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$106 Million7.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.39MShares$90.9 Million0.01% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.03B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...